The page lists 39 projects related to the topic "deregulated".
| # | |||
|---|---|---|---|
| 1 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 | 
| 2 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 | 
| 3 | PRCTOERC | Novel Regulatory Principles of Polycomb Repressive Complex 2 | 2015 | 
| 4 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 | 
| 5 | ISPADMEC | Integrin specificity in rigidity sensitive proliferation, activation and directional migration of endothelial cells | 2015 | 
| 6 | HyHeat | Profiling gene expression in Hydra vulgaris following Gold Nanoparticle-mediated hyperthermia | 2015 | 
| 7 | MINERVA | Micro-RNAs of neutrophils in renal ANCA-associated vasculitis | 2016 | 
| 8 | WntTraffic | Characterising the spatial organisation and regulation of the Wnt receptor complex in stem cells and cancer | 2016 | 
| 9 | EPIGENHEART | Epigenetic control of retinoic acid-dependent genes during heart development | 2015 | 
| 10 | APOLs | Role of Apolipoproteins L in immunity and disease | 2015 | 
| 11 | TRIGGDRUG | Reactions That Translate mRNA into Drug-like Molecules | 2016 | 
| 12 | HaemMetabolome | Deciphering the Metabolism of Haematological Cancers | 2015 | 
| 13 | NutrientSensingVivo | The Physiology of Nutrient Sensing by mTOR | 2016 | 
| 14 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 | 
| 15 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 | 
| 16 | M6Abolic-RNA-duplex | Metabolic control of RNA-protein and RNA-RNA interactions in cellular transformation. | 2016 | 
| 17 | ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity | 2016 | 
| 18 | WntELECT | Wnt Enhancer LandscapE CharacTerization | 2016 | 
| 19 | Schizophrenia Organoids | Understanding the role of parvalbumin interneuron development in schizophrenia using human cerebral organoids | 2017 | 
| 20 | BCM-UPS | Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies | 2016 | 
| 21 | CentrioleBirthDeath | Mechanism of centriole inheritance and maintenance | 2017 | 
| 22 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 | 
| 23 | BONEPHAGY | Defining the role of the FGF – autophagy axis in bone physiology | 2017 | 
| 24 | POLYAMACHINES | The polyA machinery: Elucidating the molecular mechanisms of mRNA polyadenylation, deadenylation and RNA recognition | 2017 | 
| 25 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 | 
| 26 | SPLICANCER | Regulation and reprogramming of alternative splicing in cellular transformation | 2017 | 
| 27 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 | 
| 28 | MACULA2 | Commercialising a novel diagnostic panel for patient stratification in Age-related MACULAr Degeneration | 2017 | 
| 29 | TECNEC | Preclinical concept validation of tumor endothelial cell metabolism for novel anti-angiogenic therapy | 2017 | 
| 30 | NonChroRep | Investigating the role of the long noncoding transcriptome in chromatin replication | 2018 | 
| 31 | STEMpop | Mechanisms of stem cell population dynamics and reprogramming | 2018 | 
| 32 | TCAPS | mRNA cap regulation and function in CD8 T cells | 2018 | 
| 33 | TET2rec | Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions | 2018 | 
| 34 | POLICE | The PIDDosome in Centrosome and Ploidy-Surveillance | 2018 | 
| 35 | INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer | 2018 | 
| 36 | APOSITE | Apoptotic foci: composition, structure and dynamics | 2019 | 
| 37 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 | 
| 38 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 | 
| 39 | Proteomes-in-3D | Three-dimensional dynamic views of proteomes as a novel readout for physiological and pathological alterations | 2020 |